Please try another search
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, manufacture, and sale of in-vitro diagnostic products China and internationally. Its products portfolio includes molecular diagnostic products, such as PCR system, nucleic acid extraction and purification instrument, and sample release reagent; blood gas analyzer; immuno diagnosis, including chemiluminescence immunoassay, fluorescence immunity, and immunoquantitative analyzer; and automatic coagulation analyzer. The company also provides emergency and critical illness information solutions, including software, hardware, and certification consulting services; and third-party medical inspection services. It offers products in the areas of cardiovascular and cerebrovascular diseases, infectious diseases, kidney diseases, diabetes, infectious diseases, prenatal and postnatal care, health examination, thyroid, hormones, blood gas, coagulation, drug metabolism, pathogen detection, etc. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. was founded in 2008 and is based in Wuhan, China.
Name | Age | Since | Title |
---|---|---|---|
Chen Li Li | 49 | 2013 | Chairman & GM |
Zhen Lu Zhang | 60 | - | Non-Independent Director |
Xianwang Shi | 55 | 2022 | Independent Director |
Jincheng Xie | 62 | 2022 | Independent Director |
Yi Quan | 37 | 2022 | Independent Director |
Zhao You Wen | 35 | - | Member of the Supervisory Board |
Wang Ying | 49 | 2013 | Vice Chairman & Deputy GM |
Chao Jin Bo | 33 | - | Employee Member of the Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review